Research peptides for reducing systemic and local inflammation, cytokine modulation, and inflammatory disease.
Chronic inflammation underlies most age-related diseases, from cardiovascular disease to neurodegeneration. Several peptides have demonstrated potent anti-inflammatory effects through cytokine modulation, NF-κB inhibition, and immune system regulation — often with more targeted mechanisms than NSAIDs or corticosteroids.
Research Disclaimer: All content on this page is for educational and research purposes only. These compounds are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide protocol.
BPC-157 is one of the most potent anti-inflammatory peptides studied. It reduces pro-inflammatory cytokines (TNF-α, IL-6, IL-1β), inhibits NF-κB activation, and promotes resolution of inflammation through multiple pathways.
KPV is a tripeptide derived from alpha-MSH with direct anti-inflammatory activity. It reduces intestinal inflammation and has shown efficacy in inflammatory bowel disease models. It is particularly effective for gut inflammation.
TB-500 modulates the inflammatory response by promoting actin polymerization and cell migration, which accelerates the transition from inflammatory to proliferative phase of healing.
LL-37 is an endogenous antimicrobial peptide with anti-inflammatory properties. It modulates TLR signaling and reduces excessive inflammatory responses, particularly in the context of infection.
BPC-157 has the broadest anti-inflammatory evidence across multiple tissue types and inflammatory pathways. For gut-specific inflammation, KPV has more targeted evidence.
Peptides work through different mechanisms than NSAIDs and are not direct replacements. However, they may be preferable for chronic inflammation management due to their favorable safety profiles and tissue-healing properties.
BPC-157 typically shows anti-inflammatory effects within 1–2 weeks. Structural healing and full resolution of chronic inflammation takes longer — typically 4–12 weeks depending on the condition.
Purgo Labs provides pharmaceutical-grade research peptides with third-party COAs. Use code HEALTH for 15% off your first order.
Visit Purgo LabsMedical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.